KEDM.com on X
Phoenician Capital is bullish on Halozyme Therapeutics $HALO. This company strongly focuses on licensing – and is doing that exceptionally well. Worth looking into. https://t.co/AD8KGejKA4
NASDAQ
HALO
2 stories
$13B Market cap · 2026-10-08
Phoenician Capital is bullish on Halozyme Therapeutics $HALO. This company strongly focuses on licensing – and is doing that exceptionally well. Worth looking into. https://t.co/AD8KGejKA4
@Borlaug_ @SouthernValue95 Thanks. How do you think this dynamic sets up for Halozyme $HALO?